Hoang, N., Kim, S., Long, N., et.a
People in that low-GLP-1 group also had lower levels of two other hormones that help signal fullness
Caveat #1: Reports can be made by anyone Reports to FAERS can be made by consumers (i.e., the general public) and healthcare professionals alike
The therapeutic mechanism of TUDCA in liver cirrhosis may involve promotion of bile secretion, reduction of endogenous bile acid toxicity, inhibition of apoptosis, and alleviation of endoplasmic reticulum stress (Pan et al., 2013)
(2511.HK), a biopharmaceutical company specialising in the development of multifunctional, multi-targeted therapies for chronic metabolic diseases, announced positive 52-week safety and efficacy results from the open-label extension (OLE) phases of two Phase III trials (SYMPHONY-1 and SYMPHONY-2) evaluating HTD1801 in patients with type 2 diabetes mellitus (T2DM)
Eur Heart J 44(39):40434140